Replies to post #185 on Sanuwave Health Inc (SNWV)

[si30]

Back in 2011, the price ran up to the $5-$6 range in anticipation of the Phase 3 results. This time, in my opinion, there is a greater likelihood of success in Phase 3 based on the trial design, etc. Therefore, I would think that this should run up to around the same dollar price, IMO. Just surprised we haven't seen any movement yet.